









Markets
/
Stocks
/
nasdaq-incr
/

InterCure Ltd

INCR

1.370USD

-0.090-6.16%

Market hours （ET）Quotes delayed by 15 min

62.43MMarket Cap

2.99P/E TTM



InterCure Ltd

1.370

-0.090-6.16%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of InterCure Ltd

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

InterCure Ltd's Score

Industry at a Glance

Industry Ranking

65 / 78

Overall Ranking

478 / 4617

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

InterCure Ltd Highlights

StrengthsRisks

InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Fairly Valued

The company’s latest PE is 0.00, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 2.52M shares, decreasing 20.52% quarter-over-quarter.

Financial Health

Currency: USD Updated: 2025-11-03

The company's current financial score is 3.54, which is lower than the Healthcare Providers & Services industry's average of 7.24. Its financial status is stable, and its operating efficiency is low.

Score

Industry at a Glance

Previous score

3.54

Change



Financials

6.34

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

0.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

1.37

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

4.98

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

5.00

Key Metrics

Free cash flow

No Data

InterCure Ltd's Company Valuation

Currency: USD Updated: 2025-11-03

The company’s current valuation score is 7.64, which is higher than the Healthcare Providers & Services industry's average of 7.09.

Score

Industry at a Glance

Previous score

7.64

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 65/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-03

There is no earnings forecast score for this company; the Healthcare Providers & Services industry's average is 7.56.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-03

The company’s current price momentum score is 6.84, which is lower than the Healthcare Providers & Services industry's average of 6.93. Sideways: Currently, the stock price is trading between the resistance level at 1.66 and the support level at 1.29, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.44

Change

0.4

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.024

Sell

RSI(14)

44.998

Neutral

STOCH(KDJ)(9,3,3)

49.363

Buy

ATR(14)

0.071

High Vlolatility

CCI(14)

-51.551

Neutral

Williams %R

53.333

Neutral

TRIX(12,20)

-0.395

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.418

Sell

MA10

1.446

Sell

MA20

1.524

Sell

MA50

1.550

Sell

MA100

1.544

Sell

MA200

1.542

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-03

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Rabinovitch (Alexander)

14.24M

+17.02%

Ibex Investors LLC

1.89M

Healthcare Of Ontario Pension Plan

212.50K

AdvisorShares Investments, LLC

108.88K

+0.78%

Moore Capital Management, LP

Star Investors

97.27K

Renaissance Technologies LLC

Star Investors

48.90K

+1.03%

Citadel Advisors LLC

41.07K

-2.95%

Dimensional Fund Advisors, L.P.

28.91K

Geode Capital Management, L.L.C.

22.54K

BlackRock Financial Management, Inc.

17.23K

Risk Assessment

Currency: USD Updated: 2025-11-03

The company’s current risk assessment score is 2.84, which is lower than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 1.47. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.